/
ENvue Medical, Inc. (the Company ), formerly known as NanoVibronix, Inc., was incorporated as a Delaware corporation in October 2003. In December 2025, the Company changed its name from NanoVibronix, Inc. to ENvue Medical, Inc.
The business is unprofitable at the operating level (-896.55% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 0.2% YoY. Margins deteriorated 756.5pp alongside, both lines moving the wrong way.
ROIC dropped from -47.21% to -95.94%, capital efficiency is deteriorating. Negative free cash flow of -$9M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$2M
▼ -0.2% YoY
Net Income (TTM)
-$20M
▼ -390.8% YoY
Op. Margin
-1134.71%
▼ -756.5pp YoY
ROIC
-50.73%
▼ -48.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$12M
▼ -274.4% YoY
Op. Cash Flow (TTM)
-$12M
▼ -272.5% YoY
Net Debt
-$1M
Net Cash Position
Cash & Equiv.
$2M
5Y CAGR: +32.6%
Continue Research